| Authors: |
Aghili Pour H; Division of Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany., Fiedler SA; Division of Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany., Hoch J; Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany., Humpe A; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Sitzmann N; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany., Wessiepe M; Institute for Transfusion Medicine and Cell Therapeutics, University Hospital RWTH Aachen, Aachen, Germany., Frankenberger T; Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany., Vajcs D; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU Medizin, LMU University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany., Adrian M; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Heidelberg, Germany., Klump H; Institute for Transfusion Medicine and Cell Therapeutics, University Hospital RWTH Aachen, Aachen, Germany., Hoffelner M; Division of Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany., Oberle D; Division of Infectiology, Paul-Ehrlich-Institut, Langen, Germany., Funk MB; Division of Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany. |
